State Street’s Xeris Biopharma Holdings XERS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$17.7M Buy
3,783,200
+457,945
+14% +$2.14M ﹤0.01% 2253
2025
Q1
$18.3M Sell
3,325,255
-16,619
-0.5% -$91.2K ﹤0.01% 2187
2024
Q4
$11.3M Buy
3,341,874
+137,156
+4% +$465K ﹤0.01% 2553
2024
Q3
$9.13M Sell
3,204,718
-53,915
-2% -$154K ﹤0.01% 2664
2024
Q2
$7.33M Buy
3,258,633
+43,617
+1% +$98.1K ﹤0.01% 2746
2024
Q1
$7.11M Buy
3,215,016
+490,890
+18% +$1.08M ﹤0.01% 2765
2023
Q4
$6.4M Buy
2,724,126
+154,004
+6% +$362K ﹤0.01% 2830
2023
Q3
$4.78M Buy
2,570,122
+25,224
+1% +$46.9K ﹤0.01% 2940
2023
Q2
$6.67M Buy
2,544,898
+261,327
+11% +$685K ﹤0.01% 2856
2023
Q1
$3.72M Buy
2,283,571
+138,341
+6% +$225K ﹤0.01% 3105
2022
Q4
$2.85M Sell
2,145,230
-29,013
-1% -$38.6K ﹤0.01% 3267
2022
Q3
$3.39M Buy
2,174,243
+53,508
+3% +$83.5K ﹤0.01% 3250
2022
Q2
$3.27M Buy
2,120,735
+1,735,974
+451% +$2.67M ﹤0.01% 3302
2022
Q1
$985K Buy
384,761
+18,252
+5% +$46.7K ﹤0.01% 3820
2021
Q4
$1.07M Buy
366,509
+149,627
+69% +$438K ﹤0.01% 3800
2021
Q3
$531K Buy
216,882
+2,200
+1% +$5.39K ﹤0.01% 3952
2021
Q2
$874K Sell
214,682
-569,857
-73% -$2.32M ﹤0.01% 3690
2021
Q1
$3.54M Buy
784,539
+16,460
+2% +$74.2K ﹤0.01% 3196
2020
Q4
$3.78M Buy
768,079
+92,520
+14% +$455K ﹤0.01% 3106
2020
Q3
$4.01M Buy
675,559
+56,161
+9% +$333K ﹤0.01% 2889
2020
Q2
$1.65M Buy
619,398
+77,367
+14% +$206K ﹤0.01% 3256
2020
Q1
$1.06M Buy
542,031
+41,630
+8% +$81.2K ﹤0.01% 3292
2019
Q4
$3.53M Buy
500,401
+33,950
+7% +$239K ﹤0.01% 3016
2019
Q3
$4.59M Buy
466,451
+67,820
+17% +$667K ﹤0.01% 2825
2019
Q2
$4.56M Buy
398,631
+183,285
+85% +$2.1M ﹤0.01% 2876
2019
Q1
$2.16M Buy
215,346
+116,632
+118% +$1.17M ﹤0.01% 3123
2018
Q4
$1.68M Buy
98,714
+35,789
+57% +$608K ﹤0.01% 3182
2018
Q3
$1.11M Buy
+62,925
New +$1.11M ﹤0.01% 3388